
News|Articles|February 17, 2024
Global Use of Nonprescription Weight-Loss Products Among Adolescents: 5 Key Takeaways
Author(s)Erin O'Brien
What does recent research tell us about use of nonprescription weight-loss products among teens?
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation
2
Future DSM Plans Overlook Core Problem of Validity
3
Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease
4
Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia
5









